Treatment of Relapsed/Refractory Myeloma (excluding T-cell redirection therapy)
A Discrete Choice Experiment analysis to understand Treatment Preferences of Patients with Relapsed or Refractory Multiple Myeloma (RRMM) in the United States
Beth Faiman, PhD, MSN, APN-BC, BMTCN, AOCN, FAAN, FAPO (she/her/hers)
Nurse Practitioner and Researcher
Cleveland Clinic
Highland Heights, Ohio, United States